emjreviews.com · Сайты
В каталоге с 8 ноября 2026 · показатели пересчитываются каждый час
European Medical Journal — сайт в рубрике «Медицина и здоровье», регион — Великобритания. Публикует в среднем 1,9 материала в день. Последняя публикация — 11 часов назад. Данные ТелеМакс, обновляются каждый час.
Посещаемость этого сайта измерить нечем: издание не публикует открытый счётчик, а оценивать её по косвенным признакам мы не беремся — такую цифру нельзя ни проверить, ни опровергнуть. Поэтому сайт показывается только по прямой ссылке и не участвует в рейтингах каталога. Материалы и их отклик в соцсетях ниже собраны как обычно.
История копится с момента попадания сайта в каталог: мы показываем только измеренные дни и не дорисовываем прошлое. График появится, как только наберётся несколько замеров.
The €8 million HERMOD project will support a European trial of HER-096 in people with newly diagnosed Parkinson’s. The post European Collaboration Advances Research into Parkinson’s Treatment appeared first on European Medical Journal .
A review of 74 studies identified right ventricular dysfunction as an important predictor of mortality and hospitalisation in HFpEF. The post Right Ventricular Dysfunction Predicts Poor Heart Failure Outcomes appeared first on European Medical Journal .
Aspen secures generic semaglutide approvals in Brazil and South Africa, with launches expected in the coming months. The post Aspen wins generic semaglutide approval in Brazil and South Africa appeared first on European Medical Journal .
Stem-cell transplantation has been linked to sustained progression-free survival in many patients with systemic sclerosis, with the longest follow-up to date. The post Systemic Sclerosis: Long-Term Outcomes After Stem-Cell Transplantation appeared first on European Medical Journal .
A UK longitudinal study found psoriasis was associated with numerous comorbidities across organ systems, including liver disease, substance misuse and respiratory disease. The post Psoriasis Linked to Wide Range of Long-Term Comorbidities appeared first on European Medical Journal .
Adverse pregnancy outcomes rise markedly following systemic lupus erythematosus diagnosis, demanding specialized reproductive care. The post ACR 2026: Lupus Pregnancy Risks and Counseling Tools appeared first on European Medical Journal .
Higher blood levels of two PFAS were linked to ER-negative breast cancer, but not clearly to breast cancer overall. The post Forever Chemicals Linked to ER-Negative Breast Cancer appeared first on European Medical Journal .
The latest edition of EMJ Diabetes is out now, featuring coverage from the European Association for the Study of Diabetes... The post The latest edition of EMJ Diabetes appeared first on European Medical Journal .
In this episode of Onc Now, Lennard Lee explores the latest advances in personalised cancer vaccines, emerging clinical evidence... The post Onc Now: Cancer Vaccines and Agentic AI appeared first on European Medical Journal .
A Phase 2A trial found that saroglitazar significantly reduced hepatic fat and improved liver enzymes and lipid parameters in women with PMOS and MASLD. The post Saroglitazar Improves Liver Health in Women With PCOS/PMOS appeared first on European Medical Journal .